These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8213355)

  • 1. Enhancing in vivo effect of propranolol on human lymphocyte function is not due to stereospecific beta-adrenergic blockade.
    Mangge H; Pietsch B; Lindner W; Warnkross H; Leb G; Schauenstein K
    Agents Actions; 1993 Mar; 38(3-4):281-5. PubMed ID: 8213355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic beta-adrenergic antagonist treatment affects human T lymphocyte responsiveness "in vitro".
    Malec PH; Zeman K; Markiewicz K; Tchórzewski H
    Allergol Immunopathol (Madr); 1990; 18(2):83-5. PubMed ID: 1973587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mitogen-mediated Beta-adrenergic receptor modulation in murine T lymphocytes depending on the thyroid status.
    Klecha AJ; Barreiro Arcos ML; Genaro AM; Gorelik G; Silberman DM; Caro R; Cremaschi GA
    Neuroimmunomodulation; 2005; 12(2):92-9. PubMed ID: 15785111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockade enhances adrenergic immunosuppression in rats via inhibition of melatonin release.
    Liebmann PM; Hofer D; Felsner P; Wölfler A; Schauenstein K
    J Neuroimmunol; 1996 Jul; 67(2):137-42. PubMed ID: 8765337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer.
    Baramki D; Koester J; Anderson AJ; Borish L
    J Allergy Clin Immunol; 2002 Mar; 109(3):449-54. PubMed ID: 11897990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-adrenergic agents on the murine lymphocyte response to mitogen stimulation.
    Johnson DL; Ashmore RC; Gordon MA
    J Immunopharmacol; 1981; 3(2):205-19. PubMed ID: 6121831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased human lymphocyte beta-adrenergic receptor density following chronic propranolol treatment.
    Aarons RD; Nies AS; Gal J; Molinoff PB
    Proc West Pharmacol Soc; 1979; 22():175-6. PubMed ID: 229487
    [No Abstract]   [Full Text] [Related]  

  • 9. The anticonvulsant effects of propranolol and beta-adrenergic blockade.
    Jaeger V; Esplin B; Capek R
    Experientia; 1979 Jan; 35(1):80-1. PubMed ID: 217715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol.
    Aarons RD; Molinoff PB
    J Pharmacol Exp Ther; 1982 May; 221(2):439-43. PubMed ID: 6281414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual differences in beta-receptor density contribute to variability in response to beta-adrenoceptor antagonists.
    Zhou HH; Silberstein DJ; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1989 Jun; 45(6):587-92. PubMed ID: 2543534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis.
    Oberbeck R; Schmitz D; Wilsenack K; Schüler M; Pehle B; Schedlowski M; Exton MS
    Neuroimmunomodulation; 2004; 11(4):214-23. PubMed ID: 15249727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral beta-adrenergic receptors.
    Cunnick JE; Lysle DT; Kucinski BJ; Rabin BS
    Pharmacol Biochem Behav; 1990 Jul; 36(3):645-51. PubMed ID: 2165621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls.
    Zohar J; Bannet J; Drummer D; Fisch R; Epstein RP; Belmaker RH
    Biol Psychiatry; 1983 May; 18(5):553-60. PubMed ID: 6305430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.
    Giudicelli Y; Lacasa D; Agli B; Leneveu A
    Eur J Clin Pharmacol; 1984; 26(1):7-12. PubMed ID: 6325205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
    Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans.
    Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
    Clin Pharmacol Ther; 1992 May; 51(5):549-54. PubMed ID: 1316824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in lymphocyte beta-receptor sensitivity to propranolol.
    Johnson JA
    Life Sci; 1993; 53(4):297-304. PubMed ID: 8392129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on sympathetically mediated leg vasoconstriction in humans.
    Pellinger TK; Halliwill JR
    J Physiol; 2007 Sep; 583(Pt 2):797-809. PubMed ID: 17627989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.